Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
No Data Available.
Synonyms :
meloxicam
Class :
Anti-inflammatory drugs and non-steroidal anti-inflammatory drugs (NSAIDs)
Dosage Forms & StrengthsÂ
Capsule, Oral:Â
5 mgÂ
10 mg Â
Injectable, Intravenous:Â
30 mg/ml (1ml)Â Â
Suspension, Oral:Â
7.5 mg/5ml (100 ml)Â Â
Tablet, Oral:Â
7.5 mgÂ
15 mg Â
Tablet disintegrating, Oral:Â
7.5 mgÂ
15 mg Â
Note: Lowest effective dose should be administered; administration is recommended in combination with proton pump inhibitor in patients with existing or at risk of cardiovascular disease, GI disease, kidney impairment, and chronic liver diseaseÂ
Do not change the dosage form and strength prescribed by your doctorÂ
No safe and efficacious dosing instructions were found.Â
Refer to adult dosingÂ
Note: For higher doses in patients >60 years of age: Dual antiplatelet or an anticoagulant is recommended.Â
may increase the risk or severity of methemoglobinemia when miltefosine is combined
interaction with NSAIDs may lead to increased toxicity such as myelosuppression, renal toxicity, and GI toxicity
interaction with NSAIDs may lead to increased toxicity such as myelosuppression, renal toxicity, and GI toxicity
may enhance the serum concentration of CYP2C19 Inhibitors
may enhance the serum concentration of CYP2C19 Inhibitors
It may enhance the toxicity when combined with mipomersen
Combining meloxicam with pranlukast may cause a reduction in the meloxicam’s metabolism
When meloxicam is used together with sertraline, the risk or seriousness of bleeding may be enhanced
When cyclacillin is used together with meloxicam, this leads to increased risk or seriousness of methemoglobinemia
When meloxicam is used together with bufexamac, this leads to enhanced risk or seriousness of adverse outcomes
when aclarubicin is combined with meloxicam, there is an increased risk of methemoglobinemia
meloxicam leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
When meloxicam is used together with nifenazone, this leads to enhanced risk or seriousness of adverse events
When meloxicam is used together with diazoxide, this leads to reduction in therapeutic effectiveness of diazoxide
when both drugs are combined, the risk or severity of adverse effects increases  
when combined may increase anticoagulation
when combined may increase anticoagulation
may increase the anticoagulation effect when combined
the risk of methemoglobinemia may be increased
the risk of methemoglobinemia can be increased
when both drugs are combined, there may be an increased effect of meloxicam by acidic (anionic) drug competition for renal tubular clearance 
sulfamethoxazole increases the effect of meloxicam by altering hepatic CYP2C9/10 enzyme metabolism
Significant considerations:Â
Acute myocardial infarctionÂ
Cerebrovascular accidentÂ
Heart failure Â
Frequency defined:Â Â Â
>10%Â
EdemaÂ
Increased liver enzymesÂ
Abdominal painÂ
Dyspepsia Â
Flatulence Â
Gastrointestinal bleedingÂ
NauseaÂ
vomitingÂ
TremorÂ
WeaknessÂ
Visual disturbanceÂ
AmnesiaÂ
AnxietyÂ
DrowsinessÂ
HeadacheÂ
Anxiety Â
InsomniaÂ
Malaise Â
NervousnessÂ
Skin rashÂ
Â
<1% postmarketing:Â
Altered sense of smellÂ
Anemia Â
Cardiac failureÂ
Cerebra; ischemiaÂ
ConfusionÂ
Cardiac failureÂ
EpistaxisÂ
Hepatitis Â
HepatotoxicityÂ
StomatitisÂ
Urticaria Â
VasodilationÂ
NecrolysisÂ
Peptic ulcer Â
Pregnancy consideration: Some studies reported the risk of miscarriage associated with NSAIDsÂ
Lactation: meloxicam can be excreted in breast milk. The lowest possible dose is recommended for lactating females. Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: MeloxicamÂ
Pronounced: meloxicam Â
Why do we use meloxicam?Â
Meloxicam is used to treat different types of arthritis. It is used to ease the pain. It can be prescribed by your doctor for many other reasons.Â